Latest Headlines
PR Newswire
Insilico Medicine Announce US$888 Million Multi-Year Collaboration with Servier for Drug Discovery and Development in Oncology
8 小时前
PR Newswire
Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes
8 小时前
PR Newswire
Ascentiz Debuts World's 1st Modular Exoskeleton at CES 2026, Showcasing Revolutionary Swappable Hip and Knee Support
8 小时前
It's better on the app
👈 Scan the QR code to download